Links to articles in the current and previous 2 issues of this bulletin are displayed below.
To receive email notifications about new issues of this bulletin, please email: richard.fallis@healthcarelibrary.qub.ac.uk
Are systemic corticosteroids effective and safe for treating patients with radicular and non-radicular low back pain? A Cochrane Review summary with commentary 10.1111/1756-185X.15058
Bony proliferations in rheumatoid arthritis, psoriatic arthritis and osteoarthritis using high-resolution peripheral quantitative computed tomography 10.1111/1756-185X.15068
Causal factors for osteoarthritis: a scoping review of Mendelian randomization studies 10.1002/acr.25252
Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis 10.1136/ard-2023-224014
Diagnostic accuracy of ultrasound for assessment of synovial abnormalities among patients with knee pain: a meta-analysis 10.1002/acr.25205
Evaluation of assessable telemedicine in patients with rheumatoid arthritis 10.1111/1756-185X.15007
Impact of risk factors on COVID-19 outcomes in unvaccinated people with rheumatic diseases 10.1002/acr.25220
Implication of intestinal microbiota in the etiopathogenesis of fibromyalgia 10.1111/1756-185X.15021
Is it possible to predict which patients are most likely to benefit from intra-articular corticosteroid injections? 10.1111/1756-185X.15005
Meta-analysis reveals that rheumatoid arthritis is associated with worse clinical outcomes among patients with COVID-19 10.1111/1756-185X.15049
Methotrexate for juvenile idiopathic arthritis (updated Cochrane review) 10.1002/14651858.CD003129.pub2
New approach to testing treatments for osteoarthritis: FastOA 10.1136/ard-2023-224675
Prevalence, severity, and measures of anxiety in rheumatoid arthritis 10.1002/acr.25245
Rheumatology and Long COVID: lessons from the study of fibromyalgia 10.1136/ard-2023-224250
Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story 10.1136/ard-2023-223850
Systematic review of health-related quality of life impact in juvenile localized scleroderma 10.1002/acr.25243
Transcranial direct current stimulation for knee osteoarthritis 10.1002/acr.25249
What is the role of risedronate in the primary and secondary prevention of fractures associated with osteoporosis in postmenopausal women? A Cochrane review summary with commentary 10.1111/1756-185X.14940
Annals of the Rheumatic Diseases (Feb-Mar); Arthritis Care and Research (Feb-Mar); Cochrane Library (Feb-Mar); International Journal of Rheumatic Diseases (Jan-Mar)
2022 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis DOI: 10.1002/acr.25240
Barriers and enablers in the use of parenteral methotrexate in rheumatoid arthritis patients: a scoping review DOI: 10.1002/acr.25141
Burden of knee osteoarthritis in 204 countries and territories, 1990–2019: results from the Global Burden of Disease Study 2019 DOI: 10.1002/acr.25158
Contributions of joint damage-related events to gout pathogenesis: new insights from laboratory research DOI: 10.1136/ard-2023-224679
COVID-19 and Rheumatology: Emerging Insights and Impacts (special issue of Arthritis Care and Research)
Global, regional and national temporal trends in prevalence for musculoskeletal disorders in women of childbearing age, 1990–2019: an age-period-cohort analysis based on the Global Burden of Disease Study 2019 DOI: 10.1136/ard-2023-224530
HLA-B27, axial spondyloarthritis and survival DOI: 10.1136/ard-2023-224434
Impact of obesity and overweight on C-reactive protein concentrations and disease activity in rheumatoid arthritis: A systematic review and meta-analysis DOI: 10.1111/1756-185X.14948
Major adverse cardiovascular events and mortality with opioids versus NSAIDs initiation in patients with rheumatoid arthritis DOI: 10.1136/ard-2023-224339
Prevalence of nonsteroidal antiinflammatory drugs prescribed for osteoarthritis: a systematic review and meta-analysis of observational studies DOI: 10.1002/acr.25157
Role of hydrogels in osteoarthritis: A comprehensive review DOI: 10.1111/1756-185X.14968
Sex differences in pain and quantitative sensory testing in patients with rheumatoid arthritis DOI: 10.1002/acr.25178
T follicular helper cells and T peripheral helper cells in rheumatic and musculoskeletal diseases DOI: 10.1136/ard-2023-224225
Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study DOI: 10.1136/ard-2023-224185
Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica DOI: 10.1136/ard-2022-223429
Sources used: Annals of the Rheumatic Diseases (Nov, Dec, Jan); Arthritis Care and Research (Nov, Dec, Jan); International Journal of Rheumatic Diseases (Dec)
Annals of the Rheumatic Diseases collection on autoantibodies in the rheumatic diseases: new insights into pathogenesis and the development of novel biomarkers DOI: 10.1136/ard-2023-224692
Approach to vaccination in systemic lupus erythematosus on biological treatment DOI: 10.1136/ard-2023-224071
Association of sleep disturbance with catastrophizing and knee pain DOI: 10.1002/acr.25127
Bimekizumab for treating: Axial spondyloarthritis (new NICE guideline TA918); Active psoriatic arthritis (new NICE guideline TA916)
Cartilage and bone loss in premenopausal women with rheumatoid arthritis: Radiological and laboratory assessments DOI: 10.1111/1756-185X.14915
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis DOI: 10.1136/ard-2023-224116
Clinical visit frequencies in rheumatology DOI: 10.1002/acr.25106
Core recommendations for osteoarthritis care DOI: 10.1002/acr.25101
Cryotherapy following total knee replacement (updated Cochrane intervention review) DOI: 10.1002/14651858.CD007911.pub3
Effect of systemic lupus erythematosus and immunosuppressive agents on COVID-19 vaccination antibody response DOI: 10.1002/acr.25094
Identifying and managing nociplastic pain in individuals with rheumatic diseases DOI: 10.1002/acr.25104
Incidence of primary large vessel vasculitis in Norfolk, UK from 2011 to 2020 DOI: 10.1136/ard-2023-224191
Influence of intestinal microecology in the development of gout or hyperuricemia and the potential therapeutic targets DOI: 10.1111/1756-185X.14888
Outcomes following SARS-CoV-2 infection in individuals with and without inflammatory rheumatic diseases DOI: 10.1136/ard-2023-223974
Physical activity and features of knee osteoarthritis on magnetic resonance imaging in individuals without osteoarthritis DOI: 10.1002/acr.25083
Prevalence and risk factors associated with psoriatic arthritis among patients with psoriasis DOI: 10.1111/1756-185X.14833
Recruitment and retention strategies for underrepresented populations and adults with arthritis in behavioral interventions DOI: 10.1002/acr.25098
Sources used: Annals of the Rheumatic Diseases (Sep, Oct); Arthritis Care and Research (Sep, Oct); Cochrane Library (Sep-Oct); International Journal of Rheumatic Diseases (Sep, Oct, Nov); NICE (Oct)